IMP: BOD Resolution No. 17&18.2018

Imexpharm Corporation announces BOD Resolution No. 17&18.2018 as follows:

HOSE

>   CAV: Decision on tax penalties (27/06/2018)

>   LBM: Board resolution on choosing an audit company (27/06/2018)

>   PVX: General Mandate 2018 (27/06/2018)

>   PMB: Selection of auditor for fiscal year 2018 (27/06/2018)

>   TS4: Board resolution on choosing an audit company (27/06/2018)

>   VGP: Annual General Mandate 2018 (27/06/2018)

>   VDS: Signing the audit contract (27/06/2018)

>   HNX: 04/07/2018, First trading date of new stock on UPCoM (DX2) (27/06/2018)

>   HNX: Upcom Admission of 319.2 Investment And Construction Joint Stock Company (DX2) (27/06/2018)

>   CTP: General Mandate 2018 (27/06/2018)